Fig. 8From: Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinomaKaplan–Meier analysis of recurrence-free survival on patients with high levels of CD44, CD44v6, CD44v8-10 and EpCAM with CA19-9 versus other groups of patientsBack to article page